and right trisectionectomy (13%) were the most frequently performed procedures. A total of 26 patients (55%) underwent a major ancillary procedure concurrently. There were no operative mortalities. Median operative time was 220 min (range 97-398 min). Inflow occlusion was required in nine patients (19%) for a median time of 12 min (range 3-30 min). Median total estimated blood loss was 400 ml (range 10-2000 ml) and 10 patients (21%) required perioperative transfusion. All patients had macroscopically negative margins. Median length of stay was 8 days. Two patients (4%) had clinically significant bile leak. The 30-day postoperative mortality was zero.
Introduction
The morbidity and mortality of hepatic resection have declined dramatically over the last three decades. 1, 2 This improvement has largely reflected a reduction in the amount of blood loss encountered during resection and can be attributed to improved understanding of hepatic anatomy, refinement of surgical technique and advances in surgical technology. Despite these improvements, the transection of hepatic parenchyma remains the major source of blood loss and continues to be a relative barrier to hepatic surgery.
The finger fracture method was first described in 1974 3 as the original method for controlling haemorrhage from the transection plane during hepatic parenchymal resection. The introduction of various new surgical devices has attempted to refine this method. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] For example, ultrasonic dissection has been used to atraumatically divide the hepatic parenchyma and expose the hepatic vasculature and bile ducts. The use of electrosurgical devices has allowed for the precoagulation of hepatic parenchyma and the simultaneous sealing of vessels and bile ducts during transection. With these refinements, routine hepatic resection has become relatively safe and major blood loss is infrequently encountered; however, no clearly superior method of hepatic parenchymal transection has been identified.
Despite the development of numerous technologically advanced instruments for the division of hepatic parenchyma, the use of the finger fracture method still predominates during open procedures. In a recent survey of practising high-volume liver surgeons, over 10 different devices were reported to be frequently used for parenchymal transection. The finger fracture method and the Cavitron ultrasonic surgical aspirator (CUSA) were the most often utilized methods of transection in major hepatic resection, by 58% and 43% of responding surgeons, respectively. 17 The least frequently used devices included the Enseal device and the Gyrus open forceps. The survey illustrated that a variety of methods are currently employed by active hepatic surgeons and demonstrated that choice of transection method frequently depends on surgeon preference.
Although the Gyrus open forceps was shown to be an infrequently used device in the survey, our initial experience demonstrated that its use facilitated rapid transection and excellent haemostasis, which prompted this retrospective study. The Gyrus open forceps (Gyrus ACMI, Inc., Southborough, MA, USA) is a bipolar cautery device which has been used extensively in open gynaecological surgery for a variety of surgical procedures, but has only recently been applied to hepatic surgery. When used for parenchymal transection, the Gyrus open forceps seals the hepatic parenchyma using a combination of pressure and energy that results in the fusion of collagen and elastin in the walls of the hepatic vasculature and bile ducts. The device can reliably seal vessels up to 7 mm in diameter, minimizing the amount of blood loss during transection. This report describes our initial experience using the Gyrus open forceps for hepatic parenchymal transection.
Materials and methods

Study design and patient selection
After obtaining approval from the institutional review board, a single-centre retrospective review was performed to identify patients who underwent liver resection during a 2-year period beginning in November 2005. Patients who underwent hepatic resections which utilized the Gyrus open forceps as the primary mode of transection and whose tumours required resection of at least two Couinaud liver segments were included. Data for analysis included demographics, clinical history, operative findings, pathological results, 30-day mortality and postoperative complications.
Primary endpoints included total intraoperative blood loss, the use of inflow occlusion and receipt of transfusion. The terminology used in this paper is based on the Brisbane 2000 terminology of the International Hepato-Pancreato-Biliary Association. 18 Surgical procedure All liver resections were performed in the standard manner by dedicated liver surgeons from the Section of Hepato-PancreatoBiliary Surgery, Department of Surgery, Washington University. Each patient underwent an intraoperative ultrasound examination to define the location of the tumour in relation to the major vasculature and biliary structures. All resections were performed with a low central venous pressure (0-5 mmHg). When indicated, vascular or pedicle ligation was performed in the routine manner prior to hepatic transection. Inflow occlusion was not routinely performed and only considered when the degree of blood loss was likely to result in blood transfusion.
The Gyrus open forceps ( Fig. 1 ) is a bipolar cautery device used in a similar manner to the clamp-crush technique to transect hepatic parenchyma. After incising the hepatic capsule with Bovie electrocautery, the forceps are inserted into the liver in an open manner. Using a foot pedal, bipolar energy is applied as the forceps are slowly closed over the parenchyma. An audible signal indicates the completion of the cycle. A second application of energy is often used. The cauterized liver is subsequently transected with Metzenbaum scissors. The device was used for the entire hepatic parenchymal transection; only named vascular and biliary structures required additional attention and were stapled or suture ligated.
On completion of the parenchymal transection, the cut surface of the liver was inspected for haemostasis and bile leakage. Figure 1 Gyrus open forceps Routine closed suction drainage was performed in patients who underwent biliary reconstruction, or at the surgeon's discretion.
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Results
The Gyrus device was used as the primary method of liver parenchymal transection in 58 patients undergoing liver resection at Washington University between November 2005 and November 2007. Eleven patients who underwent resection of less than two hepatic segments were excluded. The final cohort comprised 47 patients including 16 women and 31 men (median age 61 years, range 27-84 years). The most common indication for surgery was metastatic colorectal cancer confined to the liver. Less common diagnoses included hepatocellular carcinoma, cholangiocarcinoma, gallbladder cancer, metastatic breast cancer and benign disease. Patient and tumour characteristics are listed in Table 1 . The most common procedures performed were right hepatectomy (Couinaud segments 5-8, 23 patients) and left hepatectomy (Couinaud segments 1-4, six patients). Smaller numbers of patients underwent trisectionectomy (seven patients), bisegmentectomy (four patients) or mesohepatectomy (two patients) ( Table 2) .
In addition to hepatic resection, 26 patients required a concurrent ancillary procedure. Eight patients had a liver metastasis excised during the resection of their primary colorectal tumour. Bilateral metastases were present in nine patients and required non-anatomic wedge resection (six patients) or radiofrequency ablation (three patients). One patient required vascular resection and reconstruction (Table 3) .
Median operative time, inclusive of hepatic resection and all ancillary procedures, was 220 min. The median resection area was 150 cm 2 (range 40-552 cm 2 ) and was transected in a median time of 25 min (range 15-48 min). Transection time was recorded in a subset of only 15 patients. The average calculated transection speed was 4.8 cm 2 /min in this subset (Table 4) . Inflow occlusion was required in nine (19%) of 47 procedures for a median time of 12 min (range 3-30 min). Intraoperative blood loss varied from 10 ml to 2000 ml, with a median blood loss of 400 ml. Blood loss exceeding 1 litre occurred in three of 47 patients (Table 5 ). In each of these patients the majority of the blood loss occurred during associated procedures rather than during the hepatic parenchymal transection, which included en-bloc resection of a large leiomyosarcoma, placement of a hepatic artery infusion pump complicated by a tear in the inferior vena cava, and en-bloc resection of a large left upper quadrant sarcoma. Ten patients (21%) received blood transfusions in the perioperative period, including three patients intraoperatively. The median number of transfused units was zero. One patient required re-exploration for intra-abdominal haemorrhage. At the time of the second surgery, the source of haemorrhage was traced to a bleeding mesenteric vessel near the resection bed of the colorectal primary tumour, and was not related to the use of the Gyrus device. Non-anatomic wedge resection 6 (13)
Portal lymph node dissection 4 (9)
En-bloc tumour resection 4 (9)
One or more hepatic lesions treated with radiofrequency ablation (RFA)
(6)
Vascular reconstruction 1 (2) There were no postoperative mortalities within 30 days of the hepatic resection. Postoperative morbidity was observed in 14 patients (30%) and included: wound infection (one patient); deep venous thrombosis/pulmonary embolus (five patients); infectious colitis (four patients); intra-abdominal abscess (one patient); arrhythmia (one patient); non-ST elevation myocardial infarction (NSTEMI) (two patients), and respiratory insufficiency requiring re-intubation (one patient). One patient, who underwent a left lateral sectionectomy in conjunction with an en-bloc resection of a pancreatic mass, partial gastectomy, partial colectomy, splenectomy and small bowel resection, developed a pancreatic leak which resulted in septic shock with multisystem organ dysfunction, prolonged intubation, infectious colitis, NSTEMI, ileus and prolonged hospital course. No patients experienced hepatic failure. Two patients demonstrated clinical bile leak. One patient required endoscopic placement of a biliary stent across the leaking bilioenteric anastomosis. The sub-hepatic fluid collection in the second patient was presumed to have occurred secondary to ineffective bile duct closure by the device and was resolved with percutaneous drainage.
Discussion
Hepatic resection remains a challenging and demanding procedure where successful outcomes are closely linked to the ability to efficiently transect hepatic parenchyma. Successful hepatic parenchymal transection requires the simultaneous division of parenchyma and sealing of vessels and bile ducts. Numerous devices have been developed to achieve this goal; however, no single device has demonstrated clear superiority. In this paper, we retrospectively reviewed one such new device, the Gyrus open forceps, to evaluate its usefulness for hepatic parenchymal transection.
Intraoperative blood loss, and the resulting need for perioperative transfusion, can be viewed as one of the greatest negative risk factors for increased complication rates, worse postoperative outcome, and shorter disease-free survival. [19] [20] [21] In our series of 47 consecutive major liver resections, the Gyrus open forceps was demonstrated to facilitate a safe, effective and efficient method for hepatic parenchymal transection. The device uses bipolar energy to permanently seal hepatic veins and arteries along the transection plane and was routinely used for the entire hepatic parenchymal transection. The device exhibits a minimal thermal spread of 2-3 mm and was frequently used for parenchymal transection abutting the hepatic hilum. With the exception of large, named vascular and biliary structures which were routinely stapled or ligated, excellent haemostasis and biliary duct fusion were achieved uniformly. In this series, median blood loss rates compared favourably with those in several large series using the traditional clamp-crush technique. 1, 2, 22, 23 In addition, blood loss and transfusion rates were comparable with those cited in recent reports of alternative methods of parenchymal transection, 5, 9, 12, 16, 24 including our prior prospective evaluation of the LigaSure device (Table 6) .
Increased intraoperative blood loss is often associated with the increased usage of inflow occlusion. Although routine inflow occlusion is common practice during hepatic transection, there are instances where inflow occlusion may be undesirable, as in cases where the ischaemic insult may compromise the liver remnant. In these cases, where the remaining liver mass is small or compromised by preoperative jaundice, chemotherapy or underlying liver disease, the risk of hepatic failure is increased and precautions should be taken to avoid unnecessary ischaemic insult. This study demonstrates that the Gyrus open forceps can be used in a variety of major anatomic resections without the routine use of inflow occlusion.
Bile leak after hepatic resection remains a challenging complication that occurs in about 10% of patients who undergo surgery.
6,25-27 The Gyrus device was consistently able to seal bile ducts as well as vessels during transection. The rate of symptomatic bile leak requiring intervention in the current series was two in 47 patients (4.2%) and was comparable with rates reported in recent series. 6, 16, [26] [27] [28] Unlike many series, which exclude patients who require a bilioenteric reconstruction, this series includes all patients who underwent hepatic resection using the Gyrus open forceps. These included one patient who developed a bile leak after resection of a hilar cholangiocarcinoma and biliary reconstruction. A failed bilioenteric anastomosis was diagnosed by endoscopy and resolved with biliary stent placement. A second patient was diagnosed with a bile leak by computed tomography scan obtained for leucocytosis; the collection was presumed to have occurred secondary to a failure of the Gyrus device to completely seal a bile duct. The biloma resolved after radiographically guided percutaneous drainage. The rate of biliary leak attributable to the Gyrus device was 1.2% (1/47), which is slightly below rates in comparable series.
The current review suggests that the Gyrus open forceps is a rapid and efficient instrument for hepatic parenchymal transection. In the subset of patients in whom transection time was recorded, the observed rate (4.8 cm 2 /min) compared favourably with the results reported by Lesurtel et al. 24 In their prospective trial, the clamp-crush technique was demonstrated to be the most rapid method (3.9 cm 2 /min) compared with the Ultrasonic /min). Currently, the Gyrus appears to be one of the faster methods of transection. Reduced transection time offers the benefit of shorter operative times, which may lead to less morbidity and mortality related to general anaesthetic risk, operative hypothermia, and haemorrhage from the raw transection surface.
Despite the favourable findings in regard to transection time, blood loss and receipt of transfusion, perioperative morbidity in this series was 30%. However, 60% of patients who experienced multiple complications, complications requiring procedural intervention or complications resulting in organ dysfunction underwent additional procedures at the time of hepatic resection. Over half (55%) the patients underwent combined colorectal resection, en-bloc sarcoma excision or non-anatomic wedge resection of additional metastasis, which may have contributed to the relative increase in observed morbidity. The increase in morbidity may be a surrogate artefact reflecting procedural complexity.
This series has significant limitations. Most notably, this review is retrospective, which limits our ability to generalize and compare results. Additional prospective studies are required to determine whether the Gyrus open forceps is superior to other instruments currently used in hepatic parenchymal transection.
Conclusions
The Gyrus open forceps is a safe and efficient tool for hepatic parenchymal transection. Although the results of this series compare favourably with those of other reports, further prospective studies are needed to directly compare outcomes using this device with those of other methods of open hepatic parenchymal transection. 
